{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:33:30Z","timestamp":1792679610547,"version":"4.5.0"},"reference-count":105,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1631,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1755-5949.2010.00162.x","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T11:22:43Z","timestamp":1276860163000},"page":"118-132","source":"Crossref","is-referenced-by-count":188,"title":["All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors"],"prefix":"10.1111","volume":"17","author":[{"given":"Philip","family":"Seeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1192\/bjp.185.3.196","article-title":"Stimulant psychosis: Systematic review","volume":"185","author":"Curran","year":"2004","journal-title":"Brit J Psychiat"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review","volume":"20","author":"Laruelle","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archpsyc.1986.01800120048010","article-title":"Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients","volume":"43","author":"Zemlan","year":"1986","journal-title":"Arch Gen Psychiat"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0169-328X(99)00343-5","article-title":"New dopamine receptor, D2Longer, with unique TG splice site, in human brain","volume":"76","author":"Seeman","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.10.4.515","article-title":"Targeting the dopamine D2 receptor in schizophrenia","volume":"10","author":"Seeman","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/syn.20453","article-title":"Anti-Parkinson therapeutic potencies correlate with their affinities for dopamine D2High receptors","volume":"61","author":"Seeman","year":"2007","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.2042-7158.1965.tb07646.x","article-title":"Different types of sympathomimetic alpha-receptors","volume":"17","author":"Van Rossum","year":"1965","journal-title":"J Pharm Pharmacol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB9|cit9","first-page":"492","article-title":"The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs","volume":"160","author":"Van Rossum","year":"1966","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB10|cit10","first-page":"321","volume-title":"Neuro-Psycho-Pharmacology, Proceedings of the Fifth International Congress of the Collegium Internationale Neuro-Psycho-pharmacologicum","author":"Van Rossum","year":"1967"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0028-3908(64)90012-7","article-title":"Mechanism of action of psychomotor stimulant drugs. Significance of dopamine in locomotor stimulant action","volume":"3","author":"Van Rossum","year":"1964","journal-title":"Int J Neuropharmacol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB12|cit12","first-page":"246","article-title":"Dopamine receptor-block and nigral fiber-impulse blockade by major tranquilizers","volume":"33","author":"Seeman","year":"1974","journal-title":"Fed Proc"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.72.11.4376","article-title":"Brain receptors for antipsychotic drugs and dopamine: Direct binding assays","volume":"72","author":"Seeman","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB15|cit15","first-page":"663","article-title":"The brain's dopamine receptor: Labeling with [3H]dopamine and [3H]haloperidol","volume":"1","author":"Snyder","year":"1975","journal-title":"Psychopharmacol Commun"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB16|cit16","first-page":"800","article-title":"Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes","volume":"12","author":"Burt","year":"1976","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/336783a0","article-title":"Cloning and expression of a rat D2 dopamine receptor cDNA","volume":"336","author":"Bunzow","year":"1988","journal-title":"Nature"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB18|cit18","first-page":"155","article-title":"Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system","volume":"19","author":"Spano","year":"1978","journal-title":"Adv Biochem Psychopharmacol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB21|cit21","first-page":"261","article-title":"Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2, clozapine occupies D4","volume":"7","author":"Seeman","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: Mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.4249\/scholarpedia.3634","article-title":"Dopamine and schizophrenia","volume":"2","author":"Seeman","year":"2007","journal-title":"Scholarpedia"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/archgenpsychiatry.2009.43","article-title":"The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: A positron emission tomography study with [11C]-(+)-PHNO","volume":"66","author":"Graff-Guerrero","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/S0924-977X(03)91703-2","article-title":"A partial D3 receptor agonist in schizophrenia","volume":"13","author":"Lecrubier","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1566-2772(00)00007-4","article-title":"Antipsychotic drugs, dopamine receptors, and schizophrenia","volume":"1","author":"Seeman","year":"2001","journal-title":"Clin Neurosci Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0893-133X(96)00187-X","article-title":"Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors","volume":"16","author":"Seeman","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1471-4159.1984.tb06700.x","article-title":"Dopamine receptor parameters detected by 3H-spiperone depend on tissue concentration: Analysis and examples","volume":"43","author":"Seeman","year":"1984","journal-title":"J Neurochem"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0922-4106(95)90125-6","article-title":"Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand","volume":"291","author":"Seeman","year":"1995","journal-title":"Eur J Pharmacol-Mol Pharmacol Section"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin Schizophrenia & Related Psychoses"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB32|cit32","first-page":"143","article-title":"Glutamate and dopamine components in schizophrenia","volume":"34","author":"Seeman","year":"2009","journal-title":"J Psychiatry Neurosci"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/syn.20704","article-title":"Glutamate agonist LY404039 for treating schizophrenia has affinity for the dopamine D2High receptor","volume":"63","author":"Seeman","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.6147018","article-title":"Bimodal distribution of dopamine receptor densities in brains of schizophrenics","volume":"225","author":"Seeman","year":"1984","journal-title":"Science"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2high dopamine receptors","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1210\/endo-117-2-690","article-title":"The functional state of the dopamine receptor in the anterior pituitary is in the high-affinity form","volume":"117","author":"George","year":"1985","journal-title":"Endocrinology"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","article-title":"Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis","volume":"102","author":"Seeman","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/syn.20607","article-title":"Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2High receptors and marked supersensitivity to the dopamine agonist (+)PHNO","volume":"63","author":"Seeman","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/syn.20624","article-title":"Increased dopamine D2High receptors in rats reared in social isolation","volume":"63","author":"King","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/15563658408992586","article-title":"Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity","volume":"22","author":"Giannini","year":"1984","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.biopsych.2005.09.017","article-title":"High-affinity states of human brain dopamine D2\/3 receptors imaged by the agonist [11C]-(+)-PHNO","volume":"59","author":"Willeit","year":"2006","journal-title":"Biol Psychiat"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0026-895X(25)14291-0","article-title":"Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state","volume":"23","author":"Sibley","year":"1983","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/syn.20626","article-title":"Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors","volume":"63","author":"Skinbjerg","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/syn.20499","article-title":"Dopamine D2High receptors on intact cells","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuroscience.2003.08.016","article-title":"Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum","volume":"122","author":"Bhardwaj","year":"2003","journal-title":"Neuroscience"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/syn.20005","article-title":"Alcohol-withdrawn animals have a prolonged increase in dopamine D2high receptors, reversed by general anesthesia: Relation to relapse?","volume":"52","author":"Seeman","year":"2004","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","article-title":"The Trace Amine 1 receptor knockout mouse: An animal model with relevance to schizophrenia","volume":"6","author":"Wolinsky","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1111\/j.1460-9568.2008.06221.x","article-title":"Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats","volume":"27","author":"Shuto","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.euroneuro.2008.01.002","article-title":"Cocaine self-administration produces a persistent increase in dopamine D2High receptors","volume":"18","author":"Briand","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/syn.20507","article-title":"Increase of dopamine D2High receptors in the striatum of rats sensitized to caffeine motor effects","volume":"62","author":"Simola","year":"2008","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/syn.20401","article-title":"Elevated dopamine D2High receptors in alpha-1b-adrenoceptor knockout supersensitive mice","volume":"61","author":"Tassin","year":"2007","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.molbrainres.2005.07.001","article-title":"Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophrenia","volume":"140","author":"Sumiyoshi","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1111\/j.1460-9568.2003.03047.x","article-title":"The neonatal ventral hippocampal lesion model of schizophrenia: Effects on dopamine and GABA mRNA markers in the rat midbrain","volume":"18","author":"Lipska","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/syn.20620","article-title":"Rats with persistently high exploratory activity have both higher extracellular dopamine levels and higher proportion of D2High receptors in the striatum","volume":"63","author":"Alttoa","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/syn.20402","article-title":"Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity","volume":"61","author":"Seeman","year":"2007","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1471-4159.2006.03840.x","article-title":"Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography","volume":"97","author":"Ginovart","year":"2006","journal-title":"J Neurochem"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/syn.20238","article-title":"Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: A comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride","volume":"59","author":"Seneca","year":"2006","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/syn.20615","article-title":"Dopamine D2\/3 receptor occupancy of apomorphine in the nonhuman primate brain-a comparative PET study with [11C]raclopride and [11C]MNPA","volume":"63","author":"Finnema","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nucmedbio.2007.08.005","article-title":"Dopamine D2 receptor radiotracers [11C](+)-PHNO and [3H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo","volume":"35","author":"McCormick","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/syn.20671","article-title":"Ex vivo[11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro","volume":"63","author":"McCormick","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB62|cit62","first-page":"13","article-title":"Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain","volume":"340","author":"Ross","year":"1989","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/syn.20595","article-title":"Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals","volume":"63","author":"Seeman","year":"2009","journal-title":"Synapse"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/S0021-9258(19)50762-1","article-title":"Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors","volume":"267","author":"von Zastrow","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1016\/S0021-9258(17)43957-3","article-title":"Time-dependent decreases in binding affinity of agonists for beta-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization","volume":"258","author":"Insel","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(85)91576-8","article-title":"Effects of pertussis toxin on D2-dopamine receptor in rat striatum: Evidence for coupling of Ni regulatory protein with D2-receptor","volume":"333","author":"Fujita","year":"1985","journal-title":"Brain Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpsyc.62.4.371","article-title":"Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia","volume":"62","author":"Hirvonen","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.neuroimage.2005.07.038","article-title":"Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis","volume":"29","author":"Corripio","year":"2006","journal-title":"Neuroimage"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2006.01.023","article-title":"Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning","volume":"49","author":"Kellendonk","year":"2006","journal-title":"Neuron"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.schres.2008.12.024","article-title":"Schizophrenia model of elevated D2High receptors: Haloperidol reverses the amphetamine-induced elevation in dopamine D2High","volume":"91","author":"Seeman","year":"2009","journal-title":"Schizophrenia Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1076\/jhin.11.3.265.10391","article-title":"Historical development of the dopamine hypothesis of schizophrenia","volume":"11","author":"Baumeister","year":"2002","journal-title":"J Hist Neurosci"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB72|cit72","first-page":"267","article-title":"Traitement des \u00e9tats d\u2019excitation et d\u2019agitation par une m\u00e9thode m\u00e9dicamenteuse d\u00e9riv\u00e9e de l\u2019hibernith\u00e9rapie. [Therapeutic method derived from hiberno-therapy in excitation and agitation states]","volume":"110","author":"Delay","year":"1952","journal-title":"Ann M\u00e9d-Psychol (Paris)"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","article-title":"Delayed-onset hypothesis of antipsychotic action: A hypothesis tested and rejected","volume":"60","author":"Agid","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB74|cit74","first-page":"93","article-title":"The \u2018delayed onset\u2019 of antipsychotic action - an idea whose time has come and gone","volume":"31","author":"Agid","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1176\/appi.ajp.162.5.939","article-title":"Evidence for onset of antipsychotic effects within the first 24 hours of treatment","volume":"162","author":"Kapur","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.biopsych.2005.02.023","article-title":"Early-onset hypothesis of antipsychotic drug action: A hypothesis tested, confirmed and extended","volume":"57","author":"Leucht","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1176\/ajp.133.9.1076","article-title":"Rapid treatment of acute psychosis","volume":"133","author":"Anderson","year":"1976","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB78|cit78","first-page":"237","article-title":"Psychotolysis with haloperidol. Rapid control of the acutely disturbed psychotic patient","volume":"38","author":"Carter","year":"1977","journal-title":"Dis Nerv Syst."},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0006-3223(92)90124-I","article-title":"Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients","volume":"31","author":"Glovinsky","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1176\/ajp.146.10.1289","article-title":"Time course of antipsychotic effects of neuroleptic drugs","volume":"146","author":"Keck","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/appi.ajp.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","article-title":"Time course and biologic correlates of treatment response in first-episode schizophrenia","volume":"50","author":"Lieberman","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6123(08)00909-6","article-title":"In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems","volume":"172","author":"Meltzer","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.156.6.876","article-title":"Rapid release of antipsychotic drugs from dopamine D2 receptors: An explanation for low receptor occupancy and early clinical relapse upon drug withdrawal of clozapine or quetiapine","volume":"156","author":"Seeman","year":"1999","journal-title":"Am J Psychiat"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?- A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/ajp.137.2.191","article-title":"Elevation of brain neuroleptic\/dopamine receptors in schizophrenia","volume":"137","author":"Lee","year":"1980","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archpsyc.1990.01810150013003","article-title":"D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride","volume":"47","author":"Farde","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0925-4927(95)02732-D","article-title":"No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone","volume":"61","author":"Nordstr\u00f6m","year":"1995","journal-title":"Psychiatry Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.mp.4001321","article-title":"Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia","volume":"8","author":"Glatt","year":"2003","journal-title":"Mol Psychiat"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ajmg.b.30273","article-title":"The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed- and random-effects meta-analyses","volume":"141","author":"Glatt","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","article-title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database","volume":"40","author":"Allen","year":"2008","journal-title":"Nat Genet"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.135.11.1409","article-title":"Neuroleptic-induced supersensitivity psychosis","volume":"135","author":"Chouinard","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-9964(91)90050-2","article-title":"Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment","volume":"5","author":"Chouinard","year":"1991","journal-title":"Schizophr Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(78)91409-5","article-title":"Schizophrenia as dopamine-deficiency disease","author":"Chouinard","year":"1978","journal-title":"Lancet"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/070674377902400710","article-title":"Evidence of brain dopamine deficiency in schizophrenia","volume":"24","author":"Chouinard","year":"1979","journal-title":"Can J Psychiatr"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-3223(93)90044-E","article-title":"Loss of striatal cholinergic neurons as a basis of tardive and L-dopa-induced dyskinesias, and neuroleptic-induced supersensitivity psychosis","volume":"34","author":"Miller","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(99)00012-2","article-title":"A new Rating Scale for Psychotic Symptoms (RSPS). Part I. Theoretical Principles and Subscale 1: Perception Symptoms (Hallucinations and Illusions)","volume":"38","author":"Chouinard","year":"1999","journal-title":"Schizophrenia Res"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000112883","article-title":"Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes","volume":"77","author":"Chouinard","year":"2008","journal-title":"Psychother Psychosom"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1176\/appi.ajp.164.4.630","article-title":"Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: A PET study in schizophrenia","volume":"164","author":"Mizrahi","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/npp.2008.199","article-title":"The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: A clinical [11C]-(+)-PHNO PET study","volume":"34","author":"Graff-Guerrero","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/jpet.109.160598","article-title":"In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2\/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268)","volume":"331","author":"Fell","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1755-5949.2010.00162.x-BIB104|cit104","first-page":"148","volume-title":"Psychosis: Discovery of the antipsychotic receptor","author":"Seeman","year":"2009"},{"issue":"4 Suppl","key":"10.1111\/j.1755-5949.2010.00162.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1097\/00004714-198808001-00002","article-title":"Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes","volume":"8","author":"Seeman","year":"1988","journal-title":"J Clin Psychopharmacol"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-5949.2010.00162.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1755-5949.2010.00162.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:34:35Z","timestamp":1740173675000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-5949.2010.00162.x"}},"subtitle":["All Roads to Schizophrenia"],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00162.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3725956.3450054","asserted-by":"object"}]},"ISSN":["1755-5930"],"issn-type":[{"value":"1755-5930","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}